Featured Event Transfiere 2023 Málaga España Del 15/02/2023 to 17/02/2023 Healthcare Agrifood Industrial biotechnology International AseBio will play a leading role in Transfiere 2023 with talks and a stand next month in Malaga to showcase the work of...
Featured Event Apply to the first edition of AseBio-Merck Award "Advanced Therapies Startup Competition" Madrid España Del 12/09/2022 to 05/10/2022 Healthcare Advanced therapies ¡Deadline extended! You can apply until October 5th
Featured Event Biotech Communications 101 Seminar - Consilium & AseBio Investor Day On-line Del 26/04/2022 15:00 to 26/04/2022 16:00 Healthcare Communication In the framework of the AseBio Investor Day 2022 that we are holding next Thursday 28th April, our partners have the...
Featured Event The Annual 2022 Two-Day IVD Conference Madrid España Del 24/03/2022 to 25/03/2022 Healthcare
#NewAseBioMember | “AseBio is the meeting point for all companies that aim to contribute t... 14/05/2025 Healthcare Corporate Meet our new member MedBioinformatics. We sponke with Patricia Ortega Muñoz, CEO and Medical Director. AseBio - MEISYS
Prevention versus Therapy. The breakthrough of the current century 14/05/2025 Healthcare Massive data collection accelerated by the digitisation of healthcare, as well as artificial intelligence, is becoming... Partners - GENESIS Biomed
Biomedical innovation 'made in Spain': Challenges and opportunities in the long race to ma... 13/05/2025 Healthcare Access to innovation Financing Experts from the sector highlighted at the 18th Annual Conference of the Biomedical Research Technology Platforms the... AseBio
Biomedical innovation 'made in Spain': Challenges and opportunities in the long race to ma... 13/05/2025 Experts from the sector highlighted at the 18th Annual Conference of the Biomedical Research Technology Platforms the... AseBio
ORYZON awarded 13.26 million € through the first Important Project of Common European Inte... 08/05/2025 Healthcare Rare diseases Innovative drugs Oryzon to validate epigenetic agents by applying a personalized medicine approach for rare and orphan diseases. Partners - Oryzon Genomics
